Critical appraisal of a registry study: aortic valve replacement in patients aged 50-69 years.
作者信息
Glaser Natalie, Sartipy Ulrik
机构信息
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Cardiology, Stockholm South General Hospital, Stockholm, Sweden.
出版信息
Eur J Cardiothorac Surg. 2022 Jun 15;62(1). doi: 10.1093/ejcts/ezac340.
Abstract
摘要
相似文献
1
Critical appraisal of a registry study: aortic valve replacement in patients aged 50-69 years.一项注册研究的批判性评价：50至69岁患者的主动脉瓣置换术
Eur J Cardiothorac Surg. 2022 Jun 15;62(1). doi: 10.1093/ejcts/ezac340.
2
Implications of Concomitant Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement for Degenerated Surgical Aortic Bioprosthesis: Insights From the PARTNER 2 Aortic Valve-in-Valve Registry.行经导管主动脉瓣置换术治疗退行性外科生物瓣患者并发三尖瓣反流的意义：来自 PARTNER 2 主动脉瓣瓣中瓣注册研究的结果。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1154-1160. doi: 10.1016/j.jcin.2018.03.019.
3
Horizontal Aorta in Transcatheter Self-Expanding Valves: Insights From the HORSE International Multicentre Registry.经导管自膨式瓣膜中的升主动脉：来自 HORSE 国际多中心注册研究的见解。
Circ Cardiovasc Interv. 2021 Sep;14(9):e010641. doi: 10.1161/CIRCINTERVENTIONS.121.010641. Epub 2021 Aug 30.
4
Clinical outcomes after implantation of a sutureless aortic bioprosthesis with concomitant mitral valve surgery: the SURE-AVR registry.同期行二尖瓣手术植入免缝合主动脉生物瓣后的临床转归：SURE-AVR 注册研究。
J Cardiothorac Surg. 2021 May 30;16(1):154. doi: 10.1186/s13019-021-01523-w.
5
Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.Carpentier-Edwards 心包生物瓣主动脉瓣置换术的远期结果：1000 例患者长达 17 年的随访。
Ann Thorac Surg. 2010 May;89(5):1410-6. doi: 10.1016/j.athoracsur.2010.01.046.
6
Valve-in-Valve TAVR: Insights Into the Pathophysiology of Aortic Stenosis.瓣中瓣经导管主动脉瓣置换术：对主动脉瓣狭窄病理生理学的见解
J Am Coll Cardiol. 2017 May 9;69(18):2263-2265. doi: 10.1016/j.jacc.2017.03.533.
7
Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration.接受生物人工主动脉瓣植入的患者中，患者-人工瓣膜不匹配会增加因人工瓣膜结构退化而再次手术的风险。
J Card Surg. 2014 Jul;29(4):439-44. doi: 10.1111/jocs.12345. Epub 2014 Apr 29.
8
Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve-in-Valve Registry.经导管主动脉瓣置换术治疗退行性外科生物瓣二尖瓣反流患者：PARTNER 2 瓣中瓣注册研究的见解。
Catheter Cardiovasc Interv. 2020 Oct 1;96(4):981-986. doi: 10.1002/ccd.28811. Epub 2020 Mar 2.
9
Comparison of outcomes after aortic valve replacement with a mechanical valve or a bioprosthesis using microsimulation.使用微观模拟比较机械瓣膜或生物瓣膜置换主动脉瓣后的结局。
Heart. 2004 Oct;90(10):1172-8. doi: 10.1136/hrt.2003.013102.
10
Matched Comparison of Self-Expanding Transcatheter Heart Valves for the Treatment of Failed Aortic Surgical Bioprosthesis: Insights From the Valve-in-Valve International Data Registry (VIVID).用于治疗失败的主动脉外科生物瓣膜的自膨胀经导管心脏瓣膜的匹配比较：来自瓣中瓣国际数据注册库（VIVID）的见解
Circ Cardiovasc Interv. 2017 Apr;10(4). doi: 10.1161/CIRCINTERVENTIONS.116.004392.
本文引用的文献
1
Socioeconomic Status and Risk of Bleeding After Mechanical Aortic Valve Replacement.社会经济地位与机械主动脉瓣置换术后出血风险
J Am Coll Cardiol. 2022 Jun 28;79(25):2502-2513. doi: 10.1016/j.jacc.2022.04.030.
2
Surgical aortic valve replacement in patients aged 50-69 years-insights from the German Aortic Valve Registry (GARY).50-69 岁患者的外科主动脉瓣置换术——德国主动脉瓣登记研究（GARY）的见解。
Eur J Cardiothorac Surg. 2022 Jun 15;62(1). doi: 10.1093/ejcts/ezac286.
3
Comparison of Long-term Performance of Bioprosthetic Aortic Valves in Sweden From 2003 to 2018.2003 年至 2018 年瑞典生物瓣主动脉瓣的长期性能比较。
JAMA Netw Open. 2022 Mar 1;5(3):e220962. doi: 10.1001/jamanetworkopen.2022.0962.
4
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南。
Eur J Cardiothorac Surg. 2021 Oct 22;60(4):727-800. doi: 10.1093/ejcts/ezab389.
5
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2021 Feb 2;77(4):e25-e197. doi: 10.1016/j.jacc.2020.11.018. Epub 2020 Dec 17.
6
Loss in Life Expectancy After Surgical Aortic Valve Replacement: SWEDEHEART Study.主动脉瓣置换术后预期寿命的损失：SWEDEHEART 研究。
J Am Coll Cardiol. 2019 Jul 9;74(1):26-33. doi: 10.1016/j.jacc.2019.04.053.
7
Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement.用于主动脉瓣和二尖瓣置换的机械或生物假体
N Engl J Med. 2017 Nov 9;377(19):1847-1857. doi: 10.1056/NEJMoa1613792.
8
Mechanical versus bioprosthetic aortic valve replacement.机械瓣与生物瓣主动脉瓣置换术的比较。
Eur Heart J. 2017 Jul 21;38(28):2183-2191. doi: 10.1093/eurheartj/ehx141.
9
Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years.50-69 岁患者行主动脉瓣置换术：机械瓣与生物瓣的比较。
Eur Heart J. 2016 Sep 7;37(34):2658-67. doi: 10.1093/eurheartj/ehv580. Epub 2015 Nov 11.
10
Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years.50 岁至 69 岁患者行生物瓣与机械瓣主动脉瓣置换术后的生存和长期预后。
JAMA. 2014 Oct 1;312(13):1323-9. doi: 10.1001/jama.2014.12679.
Zotero 插件